Showing results (131-140 of 1,273) with videos related to
Sort By:
Pageof 128
Clinical Colorectal Cancer|January 7, 2011
Cetuximab Plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan: the LABEL studyAntonio C Buzaid, Clarissa de Cerqueira Mathias, Florencia Perazzo, et al.Clinical Colorectal Cancer|January 7, 2011
Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastasesLuis H Camacho, Sheila Garcia, Amar M Panchal, et al.Clinical Colorectal Cancer|October 20, 2007
Two Doses of oxaliplatin with capecitabine (XELOX) in metastatic colorectal cancerIsabel Moreno-Solórzano, Rafael Ibeas-Rollan, Mariano Monzó-Planella, et al.Clinical Colorectal Cancer|January 28, 2012
Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovaryChristopher R Garrett, Ben George, Chitra Viswanathan, et al.Clinical Colorectal Cancer|January 28, 2012
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinomaMichael A Morse, Brent A Hanks, Paul Suhocki, et al.Clinical Colorectal Cancer|January 27, 2012
Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastasesLudmila Katherine Martin, Anthony Cucci, Lai Wei, et al.Clinical Colorectal Cancer|February 7, 2012
Liver-directed therapies: does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases?E Seront, M Van den EyndeClinical Colorectal Cancer|January 31, 2012
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancerArjun Sood, Danielle McClain, Radhashree Maitra, et al.Clinical Colorectal Cancer|September 10, 2011
Development of novel targeted agents in the treatment of metastatic colorectal cancerEamon Berge, Chris Thompson, Wells MessersmithClinical Colorectal Cancer|September 10, 2011
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimenLorenzo Fornaro, Enrico Vasile, Gianluca Masi, et al.Pageof 128